Introduction to platform technology in pharmaceutical development MCQs With Answer

Platform technology in pharmaceutical development refers to standardized methods, tools, and processes that accelerate drug discovery, formulation, and manufacturing for multiple products. For B.Pharm students, mastering platform approaches—such as biologics and small-molecule platforms, lipid nanoparticle (LNP) and mRNA platforms, modular manufacturing, continuous processing, process analytical technology (PAT), and Quality by Design (QbD)—is vital for effective drug development. Platform strategies enhance scalability, reproducibility, regulatory compliance, and cost-efficiency across preclinical and clinical stages. This introduction outlines platform selection, process optimization, analytical validation, tech transfer, and regulatory considerations to prepare you for applying platform thinking in formulation, CMC, and manufacturing. Now let’s test your knowledge with 30 MCQs on this topic.

Q1. What best defines a platform technology in pharmaceutical development?

  • Standardized methods and tools used across multiple drug products
  • A unique, one-off manufacturing process for a single drug
  • A sales and marketing strategy for new drugs
  • A specific clinical trial design exclusive to one product

Correct Answer: Standardized methods and tools used across multiple drug products

Q2. Which is a primary advantage of using platform technologies?

  • Faster development timelines and reduced lead time to clinic
  • Always higher cost and more complexity
  • Greater regulatory uncertainty compared to bespoke processes
  • Limited scalability compared to traditional methods

Correct Answer: Faster development timelines and reduced lead time to clinic

Q3. Which is an example of a biologics platform?

  • Monoclonal antibody expression systems using CHO cells
  • Tablet compression equipment for small molecules
  • Topical cream manufacturing line
  • Gas chromatography analytical instrumentation

Correct Answer: Monoclonal antibody expression systems using CHO cells

Q4. Which platform enables rapid sequence-to-product workflows for therapeutics?

  • mRNA and lipid nanoparticle (LNP) platforms
  • Traditional tablet formulation platform
  • Lyophilization-only platform
  • HPLC analytical platform

Correct Answer: mRNA and lipid nanoparticle (LNP) platforms

Q5. What manufacturing design is commonly associated with platform technology?

  • Modular facility design with standardized unit operations
  • Unique bespoke equipment for every product
  • Randomized process routing per batch
  • Elimination of analytical testing steps

Correct Answer: Modular facility design with standardized unit operations

Q6. Which regulatory concept aligns closely with platform-based development?

  • Quality by Design (QbD)
  • Random product testing without risk assessment
  • No documentation for platform processes
  • Marketing exclusivity as the primary control

Correct Answer: Quality by Design (QbD)

Q7. What does PAT stand for in platform manufacturing?

  • Process Analytical Technology
  • Product Approval Timeline
  • Platform Application Tool
  • Preclinical Analytical Testing

Correct Answer: Process Analytical Technology

Q8. Which is a key benefit of continuous manufacturing in a platform approach?

  • Improved process control and manufacturing efficiency
  • Increased batch-to-batch variability
  • Longer production cycle times
  • Requirement for larger fixed equipment footprint

Correct Answer: Improved process control and manufacturing efficiency

Q9. What is a primary advantage of single-use systems in platform manufacturing?

  • Reduction in cleaning, validation burden and cross-contamination risk
  • Requirement for extensive cleaning validation like stainless steel
  • Incompatibility with biologics production
  • Always lower overall cost regardless of scale

Correct Answer: Reduction in cleaning, validation burden and cross-contamination risk

Q10. What is a common technical challenge during platform tech transfer?

  • Cell line-specific behavior causing process variability
  • Identical behavior across all cell lines eliminating need for testing
  • No requirement for scale-up activities
  • Automatic regulatory approval without documentation

Correct Answer: Cell line-specific behavior causing process variability

Q11. Which is an example of a formulation platform used for nucleic acid therapeutics?

  • Lipid nanoparticle (LNP) delivery platform
  • Gas chromatography method development
  • Tablet coating line
  • Dissolution apparatus

Correct Answer: Lipid nanoparticle (LNP) delivery platform

Q12. What role does high-throughput screening (HTS) play in platform drug discovery?

  • Rapid identification of lead compounds against targets
  • Only used during late-stage manufacturing
  • Replaces the need for clinical trials
  • Designs packaging and labeling for drugs

Correct Answer: Rapid identification of lead compounds against targets

Q13. In platform-based development, what does “comparability” refer to?

  • Demonstrating product similarity before and after a process change
  • Comparing marketing strategies for two products
  • Comparing two brands’ pricing and distribution
  • Measuring dissolution only for solid dosage forms

Correct Answer: Demonstrating product similarity before and after a process change

Q14. What is the purpose of Design of Experiments (DOE) in platform process development?

  • Efficiently optimize critical process variables and interactions
  • Randomly sample process parameters without structure
  • Avoid experimental work by simulation only
  • Used exclusively for stability testing

Correct Answer: Efficiently optimize critical process variables and interactions

Q15. Which analytics are commonly standardized in platform validation?

  • Bioassays, HPLC methods, and qPCR among others
  • Only visual inspection and weight checks
  • Packaging design analytics
  • Only microbiological environmental monitoring

Correct Answer: Bioassays, HPLC methods, and qPCR among others

Q16. What does scalability mean in the context of a pharmaceutical platform?

  • The ability to increase production while maintaining product quality
  • The ability to change packaging formats quickly
  • Reducing regulatory oversight at larger scale
  • Speed of clinical site recruitment

Correct Answer: The ability to increase production while maintaining product quality

Q17. What does CMC stand for in regulatory submissions for platform products?

  • Chemistry, Manufacturing and Controls
  • Clinical, Marketing and Compliance
  • Compound, Method and Category
  • Content, Measure and Control

Correct Answer: Chemistry, Manufacturing and Controls

Q18. What is a digital twin in the context of platform manufacturing?

  • A virtual process model used for simulation and optimization
  • An identical physical replica of a manufacturing facility
  • A new excipient used in formulation
  • A regulatory guideline document

Correct Answer: A virtual process model used for simulation and optimization

Q19. Which expression system is commonly used in biologics platform development?

  • Chinese Hamster Ovary (CHO) cell lines
  • Only E. coli for all biologics
  • Plant leaf expression only
  • Inert glass reactors as expression systems

Correct Answer: Chinese Hamster Ovary (CHO) cell lines

Q20. What regulatory document concept supports reuse of platform data across submissions?

  • Platform master file or technology master file
  • Marketing authorization only
  • Patent filing as the only submission
  • Clinical trial protocol reuse

Correct Answer: Platform master file or technology master file

Q21. How would you define a platform assay?

  • A standardized analytical method applied consistently across multiple products
  • An assay uniquely developed for each individual product
  • An assay used only in clinical studies
  • An assay used solely for packaging quality

Correct Answer: A standardized analytical method applied consistently across multiple products

Q22. What is an advantage of modular formulation platforms?

  • Faster tech transfer and reduced time for process adaptation
  • Requires complete process redesign for each product
  • Eliminates the need for stability studies
  • Increases impurity formation systematically

Correct Answer: Faster tech transfer and reduced time for process adaptation

Q23. Which elements are core to Quality by Design (QbD) in a platform?

  • Predefined objectives, risk assessment, and a control strategy
  • Random testing without risk tools
  • Complete elimination of process monitoring
  • Only focusing on marketing claims

Correct Answer: Predefined objectives, risk assessment, and a control strategy

Q24. Lyophilization platforms are primarily used for what purpose?

  • Stabilizing biologic molecules in a dry solid form
  • Tablet compression for oral solids
  • Gas sterilization of equipment
  • Enhancing flavor in oral formulations

Correct Answer: Stabilizing biologic molecules in a dry solid form

Q25. What is a major challenge when developing biosimilar products using a platform?

  • Demonstrating biosimilarity despite minor molecular differences
  • Biosimilars are always identical to reference products
  • No clinical data are ever required for biosimilars
  • Using cheaper raw materials guarantees success

Correct Answer: Demonstrating biosimilarity despite minor molecular differences

Q26. What is the role of PAT sensors in a platform process?

  • Real-time monitoring of critical quality attributes and control
  • Only measuring ambient room temperature
  • Replacing full quality control laboratories entirely
  • Used exclusively during clinical operations

Correct Answer: Real-time monitoring of critical quality attributes and control

Q27. Which is NOT an objective of a pharmaceutical platform?

  • Creating product-specific manual steps that prevent standardization
  • Reducing time-to-clinic across multiple candidates
  • Improving reproducibility between batches
  • Facilitating regulatory submissions using shared data

Correct Answer: Creating product-specific manual steps that prevent standardization

Q28. What is a meaningful metric to evaluate platform success?

  • Number of different products successfully developed using the platform
  • The color scheme of product packaging
  • Total sales revenue only, irrespective of process performance
  • Number of design patents unrelated to process utility

Correct Answer: Number of different products successfully developed using the platform

Q29. Which documents are typically included in tech transfer for a platform?

  • SOPs, batch records, process flow diagrams and validation protocols
  • Only marketing brochures and sales slides
  • Clinical investigator brochures only
  • Packaging artwork files only

Correct Answer: SOPs, batch records, process flow diagrams and validation protocols

Q30. When selecting a platform for a new drug candidate, which considerations are important?

  • Target molecule class, scalability, manufacturability and regulatory pathway
  • Only the current marketing trends
  • Packaging color and label design exclusively
  • Choosing the cheapest available equipment regardless of fit

Correct Answer: Target molecule class, scalability, manufacturability and regulatory pathway

Leave a Comment